围绝经期及绝经后期女性腰椎骨密度与生殖特点及性激素浓度的相关分析

doi:10.3969/j.issn.1006-7795.2023.04.004

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (4): 530-534.doi: 10.3969/j.issn.1006-7795.2023.04.004

• 妇科内分泌绝经与生育力保护 • 上一篇下一篇

围绝经期及绝经后期女性腰椎骨密度与生殖特点及性激素浓度的相关分析

刘莉莉¹, 阮祥燕^1*, 鞠蕊¹, 杨瑜¹, 蒋玲玲¹, 程姣姣¹, 李妍秋¹, 谷牧青¹, 王志坤¹, 王泽铖¹, Alfred O.Mueck^1，2

1.首都医科大学附属北京妇产医院／北京妇幼保健院内分泌科，北京 100026； 2.德国图宾根大学妇产医院妇女健康部与妇女健康研究中心，图宾根D-72076，德国

收稿日期:2023-05-09 出版日期:2023-08-21 发布日期:2023-07-26
通讯作者: 阮祥燕 E-mail:ruanxiangyan @ ccmu.edu.cn
基金资助:
北京市医院管理中心“登峰”人才培养计划项目（DFL20181401）,中国健康促进基金会专项（CHPF-2018-OP-11）

Correlation analysis of lumbar bone mineral density with reproductive characteristics and sex hormone levels in perimenopausal and postmenopausal women

Liu Lili¹，Ruan Xiangyan^1*, Ju Rui¹， Yang Yu¹， Jiang Lingling¹，Cheng Jiaojiao¹, Li Yanqiu¹, Gu Muqing¹，Wang Zhikun¹，Wang Zecheng¹, Alfred O.Mueck^1,2

1.Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University / Beijing Maternal and Child Health Care Hospital, Beijing 100026, China; 2.Department of Women's Health, Research Centre for Women's Health and University Women's Hospital of Tuebingen, University Hospitals of Tuebingen, Tuebingen D-72076, Germany

Received:2023-05-09 Online:2023-08-21 Published:2023-07-26
Supported by:
This study was supported by Beijing Municipal Administration of Hospitals Ascent Plan (DFL20181401)，China Health Promotion Foundation （CHPF-2018-OP-11）.

摘要/Abstract

摘要： 目的探讨围绝经期及绝经后期女性腰椎骨密度(bone mineral density, BMD)与生殖特点及性激素浓度之间的关系，进一步分析此时期女性骨量减少的影响因素。方法选择2021年10月至2023年2月于首都医科大学附属北京妇产医院内分泌科就诊的围绝经期及绝经后期女性328例为研究对象。采用定量电子计算机断层扫描技术（quantitative computed tomography, QCT）测量腰椎骨密度，根据测量结果分为骨量正常组和骨量减少组。采用更年期症状全面评估量表采集所有研究对象的年龄、初潮年龄、绝经状态、孕产史、哺乳时长，采用全自动化学发光免疫法测定血清卵泡刺激素（follicle stimulating hormone, FSH）、黄体生成素（luteinizing hormone, LH）、雌二醇（estradiol, E2）、孕酮（progesterone, P）及总睾酮（testosterone, T）浓度。采用单因素方差分析比较骨量正常组和骨量减少组的生殖特点及性激素浓度之间的差异性，采用多因素Logistic回归分析探讨骨量减少的危险因素。结果绝经后期女性的骨密度显著低于围绝经期女性(P<0.05)。骨量减少组女性年龄、初潮年龄、产次、哺乳时长、绝经后期占比、FSH浓度均显著高于骨量正常组(P<0.05)，而血清E2浓度显著低于骨量正常组(P<0.05)。多因素Logistic回归分析结果显示，年龄大(OR=1.088)、哺乳时间长(OR=1.057)、绝经后期(OR=5.716)是骨量减少的危险因素(P<0.05)。结论与围绝经期女性相比，绝经后期女性骨密度明显降低，围绝经期及绝经后期女性腰椎骨密度与生殖特点及性激素浓度密切相关。建议临床医生关注此时期女性的骨密度变化，以便通过及时合理的治疗来改善她们的生活质量，预防骨质疏松的发生。

关键词: 骨密度, 围绝经期及绝经后期, 生殖特点, 性激素

Abstract: Objective To explore the relationship between lumbar bone mineral density (BMD) and reproductive characteristics and sex hormone levels in perimenopausal and postmenopausal women, and to further analyze the influencing factors of bone loss in women during this period. Methods A total of 328 perimenopausal and postmenopausal women who visited Beijing Obstetrics and Gynecology Hospital, Capital Medical University from October 2021 to February 2023 were selected as subjects. Quantitative computed tomography (QCT) was used to measure lumbar bone density. According to the measurement results, the patients were divided into normal bone mass group and less bone mass group. The age, menarche age, menopausal status, pregnancy history and lactation duration of all subjects were collected with the comprehensive assessment scale of menopausal symptoms. The levels of serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), progesterone (P) and total testosterone (T) were measured with automatic chemiluminescence immunoassay. Univariate analysis was used to compare the differences in reproductive characteristics and sex hormone levels between the normal bone mass group and the osteopenia group. Multivariate Logistic regression analysis was used to explore the risk factors of osteopenia.Results The BMD of postmenopausal women was significantly lower than that of perimenopausal women ( P<0.05). Univariate analysis showed that the age, menarche age, number of deliveries, lactation duration, postmenopause ratio and FSH level of women in the less bone mass group were significantly higher than those in the normal bone mass group ( P <0.05 ). The serum E2 level was significantly lower than that in the normal bone mass group ( P <0.05 ).Multivariate Logistic regression analysis showed that older age ( OR=1.088 ), longer lactation duration ( OR=1.057 ), and postmenopause ( OR=5.716 ) were risk factors for bone loss ( P<0.05 ). Conclusion Compared with perimenopausal women, postmenopausal women have significantly lower BMD; The BMD in perimenopausal and postmenopausal women is closely related to reproductive characteristics and sex hormone levels. It is suggested that clinicians should pay attention to the changes of BMD in women during this period, so as to improve their quality of life and prevent the occurrence of osteoporosis (OP) through timely and reasonable treatment.

Key words: bone mineral density, perimenopausal and postopausal, men reproductive characteristics, sex hormones

中图分类号:

R711.75

刘莉莉, 阮祥燕, 鞠蕊, 杨瑜, 蒋玲玲, 程姣姣, 李妍秋, 谷牧青, 王志坤, 王泽铖, Alfred O.Mueck. 围绝经期及绝经后期女性腰椎骨密度与生殖特点及性激素浓度的相关分析[J]. 首都医科大学学报, 2023, 44(4): 530-534.

Liu Lili, Ruan Xiangyan, Ju Rui, Yang Yu, Jiang Lingling, Cheng Jiaojiao, Li Yanqiu, Gu Muqing, Wang Zhikun, Wang Zecheng, Alfred O.Mueck. Correlation analysis of lumbar bone mineral density with reproductive characteristics and sex hormone levels in perimenopausal and postmenopausal women[J]. Journal of Capital Medical University, 2023, 44(4): 530-534.

参考文献

［1］ Haczynski J, Jakimiuk A. Vertebral fractures: a hidden problem of osteoporosis［J］. Med Sci Monit, 2001, 7(5): 1108-1117.
［2］ Wang L H, Yu W, Yin X J, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study［J］. JAMA Netw Open, 2021, 4(8): e2121106.
［3］ Engelke K, Adams J E, Armbrecht G, et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions［J］. J Clin Densitom,2008,11(1):123-162.
［4］程晓光, 李娜, 余卫. 美国放射学院(ACR)关于定量CT(QCT)骨密度测量操作指南［J］. 中国骨质疏松杂志, 2013, 19(9): 991-997.
［5］ Harlow S D, Gass M, Hall J E, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging［J］. Menopause, 2012, 19(4): 387-395.
［6］张凌燕, 阮祥燕, 李星明, 等. 更年期症状全面评估量表的信度与效度评价［J］. 首都医科大学学报, 2021, 42(4): 511-520.
［7］仲玉侨, 王植, 孟祥虹, 等. 应用定量CT探讨绝经后女性股骨近端骨折的危险因素［J］. 放射学实践, 2022, 37(12): 1568-1572.
［8］杨春云, 邱清芳, 丛振杰, 等. 胶东半岛成年人群骨密度与年龄、身高、体重、体重指数和体表面积关系的研究［J］. 中国骨质疏松杂志, 2011, 17(1): 47-50, 59.
［9］杨云虹, 凡一诺, 章家皓, 等. 基于NHANES数据库分析女性特殊生理期相关数值与绝经后骨密度的关系［J］. 中国组织工程研究, 2023, 27(32): 5191-5195.
［10］ He Y, Huang J, Jiang G P, et al. Menarche age exceed 17 years and menopausal age smaller than 48 years may affect prevalence of osteoporosis for Chinese women［J］. Arch Osteoporos, 2021, 16(1): 123.
［11］ LeBoff M S, Greenspan S L, Insogna K L, et al. The clinician's guide to prevention and treatment of osteoporosis［J］. Osteoporos Int, 2022, 33(10): 2049-2102.
［12］ Sanz-Salvador L, García-Pérez M Á, Tarín J J, et al. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture［J］. Eur J Endocrinol, 2015: R53－R65.
［13］张丹. 妊娠与年龄对育龄妇女超声骨密度的影响［D］. 南京: 南京医科大学, 2018.
［14］ Shieh A, Ruppert K M, Greendale G A, et al. Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women［J］. J Clin Endocrinol Metab, 2022, 107(2): e561－e569.
［15］张静, 匡晓梅, 严雪文, 等. 围绝经期及绝经后女性骨密度与性激素以及人体成分的相关性分析［J］. 中国妇幼健康研究, 2021, 32(12): 1734-1739.
［16］伍西羽, 廖二元, 肖业. 卵泡刺激素抗体预防骨质疏松和肥胖［J］. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(5): 496-502.
［17］刘国敏. 更年期骨质疏松女性性激素与脂肪细胞因子、骨代谢生化指标的相关性分析［J］. 海南医学院学报, 2018, 24(2): 220-223.
［18］ Jabbar S, Drury J, Fordham J N, et al. Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis［J］. J Clin Pathol, 2011, 64(4): 354-357.
［19］ Yong E L, Logan S. Menopausal osteoporosis: screening, prevention and treatment［J］. Singapore Med J, 2021, 62(4): 159-166.
［20］ Bijelic R, Milicevic S, Balaban J. Risk factors for osteoporosis in postmenopausal women［J］. Med Arch, 2017, 71(1): 25-28.
［21］中国老年学和老年医学学会骨质疏松分会妇产科专家委员会与围绝经期骨质疏松防控培训部. 围绝经期和绝经后妇女骨质疏松防治专家共识［J］. 中国临床医生杂志, 2020, 48(8): 903-908.
［22］ Shariati-Sarabi Z, Rezaie H E, Milani N, et al. Evaluation of bone mineral density in perimenopausal period［J］. Arch Bone Jt Surg, 2018, 6(1): 57-62.

[1]	马郡, 阮祥燕, 许仲婷, 谷牧青, Alfred O.Mueck. 癸女贞胶囊对卵巢储备功能减退女性妊娠结局的影响[J]. 首都医科大学学报, 2023, 44(4): 540-543.
[2]	王志坤, 阮祥燕, 鞠蕊, 杨瑜, 蒋玲玲, 程姣姣, 李妍秋, 谷牧青, 刘莉莉, 王泽铖, Alfred O.Mueck. 围绝经期与绝经后女性雄激素浓度对情绪障碍及性功能障碍的影响[J]. 首都医科大学学报, 2023, 44(4): 517-523.
[3]	程姣姣, 阮祥燕, 杜娟, 谷牧青. 未成熟卵母细胞体外成熟在生育力保护中的应用进展[J]. 首都医科大学学报, 2022, 43(3): 329-335.
[4]	鞠蕊, 阮祥燕, 代荫梅, 白勇涛, 杨瑜, 许新, 程姣姣, 杨幸子, 施琰红, 孙艳华, 李瑞玲. 女性性功能障碍的影响因素研究[J]. 首都医科大学学报, 2022, 43(3): 357-363.
[5]	周巧云, 黄晓武, 夏恩兰, 赵玉婷, 黄睿. 子宫动脉栓塞后宫腔粘连的生殖结局分析[J]. 首都医科大学学报, 2022, 43(3): 490-494.
[6]	程姣姣, 阮祥燕, 杜娟, 金凤羽, 李扬璐, 谷牧青. 卵巢组织冻存移植安全性的研究进展[J]. 首都医科大学学报, 2021, 42(4): 505-510.
[7]	金凤羽, 阮祥燕, 杜娟, 程姣姣, 李扬璐, 王虎生, 谷牧青, 鞠蕊, 杨瑜, 王月姣, 许新. 中国首个卵巢组织冻存库冻存患者特征及冻存效果分析[J]. 首都医科大学学报, 2021, 42(4): 521-525.
[8]	鞠蕊, 阮祥燕, 代荫梅, 白勇涛, 杨幸子, 施琰红, 许新, 杨瑜, 程姣姣, 孙艳华, 李瑞玲. 不同生殖衰老分期及激素替代治疗的绝经期女性性功能障碍状况分析[J]. 首都医科大学学报, 2021, 42(4): 533-539.
[9]	王虎生, 阮祥燕, 程姣姣, Alfred O. Mueck. 肥胖型多囊卵巢综合征的氧化应激与脂代谢关系的研究[J]. 首都医科大学学报, 2021, 42(4): 540-546.
[10]	杨瑜, 阮祥燕, 鞠蕊, 许新, 谷牧青, 程姣姣. 屈螺酮炔雌醇Ⅱ对多囊卵巢综合征患者血清抗苗勒管激素的影响[J]. 首都医科大学学报, 2021, 42(4): 547-552.
[11]	刘真, 殷冬梅, 战思恩, 阮祥燕. 黄连素改善多囊卵巢综合征患者代谢异常的系统评价[J]. 首都医科大学学报, 2021, 42(4): 588-595.
[12]	豆竹丽, 阮祥燕, 鞠蕊, 王宾红, 秦爽, 许新, 杨瑜, 张露平. 综合干预后多囊卵巢综合征不孕患者应用来曲唑促排卵的临床效果[J]. 首都医科大学学报, 2020, 41(4): 525-529.
[13]	程姣姣, 阮祥燕, 杜娟, 谷牧青. 间充质干细胞对人冻融卵巢组织移植后低氧期保护作用的研究进展[J]. 首都医科大学学报, 2020, 41(4): 536-541.
[14]	谷牧青, 李扬璐, 程姣姣, 王虎生, 阮祥燕, 贾婵维. 达英-35对多囊卵巢综合征患者代谢与性激素的影响[J]. 首都医科大学学报, 2019, 40(4): 560-565.
[15]	闵敏, 阮祥燕, 赵越, 王虎生, 程姣姣, 罗穗豫, 许仲婷, 李萌, 张露平, 王月姣, Alfred O. Mueck. 奥利司他综合干预对超重或肥胖型PCOS患者雄激素及糖脂代谢的影响[J]. 首都医科大学学报, 2019, 40(4): 572-577.

围绝经期及绝经后期女性腰椎骨密度与生殖特点及性激素浓度的相关分析

Correlation analysis of lumbar bone mineral density with reproductive characteristics and sex hormone levels in perimenopausal and postmenopausal women

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价